Expressing support for the designation of the week of May 3, 2026, through May 9, 2026, as "Tardive Dyskinesia Awareness Week".

Referred to the House Committee on Energy and Commerce.

2026-05-07

This resolution designates the week of May 3-9, 2026, as "Tardive Dyskinesia Awareness Week" to increase public understanding of this serious movement disorder that can develop as a side effect of certain psychiatric medications. The designation aims to draw attention to the condition, which causes involuntary repetitive movements, and to encourage awareness among patients, healthcare providers, and the general public about its risks and management.